Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 2
1992 5
1993 4
1995 3
1999 3
2000 2
2001 3
2002 2
2003 1
2005 1
2006 1
2008 2
2009 1
2010 4
2011 6
2012 7
2013 10
2014 10
2015 4
2016 5
2017 3
2018 4
2020 1
2021 5
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

77 results
Results by year
Filters applied: . Clear all
Page 1
Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome.
Berry-Kravis EM, Lindemann L, Jønch AE, Apostol G, Bear MF, Carpenter RL, Crawley JN, Curie A, Des Portes V, Hossain F, Gasparini F, Gomez-Mancilla B, Hessl D, Loth E, Scharf SH, Wang PP, Von Raison F, Hagerman R, Spooren W, Jacquemont S. Berry-Kravis EM, et al. Among authors: gomez mancilla b. Nat Rev Drug Discov. 2018 Apr;17(4):280-299. doi: 10.1038/nrd.2017.221. Epub 2017 Dec 8. Nat Rev Drug Discov. 2018. PMID: 29217836 Free PMC article. Review.
Pathophysiology of L-dopa-induced dyskinesias.
Bédard PJ, Blanchet PJ, Lévesque D, Soghomonian JJ, Grondin R, Morissette M, Goulet M, Calon F, Falardeau P, Gomez-Mancilla B, Doucet JP, Robertson GS, DiPaolo T. Bédard PJ, et al. Among authors: gomez mancilla b. Mov Disord. 1999;14 Suppl 1:4-8. Mov Disord. 1999. PMID: 10493397 Review. No abstract available.
Rivastigmine in Parkinson's Disease Dementia with Orthostatic Hypotension.
Espay AJ, Marsili L, Mahajan A, Sturchio A, Pathan R, Pilotto A, Elango DS, Pezous N, Masellis M, Gomez-Mancilla B. Espay AJ, et al. Among authors: gomez mancilla b. Ann Neurol. 2021 Jan;89(1):91-98. doi: 10.1002/ana.25923. Epub 2020 Oct 20. Ann Neurol. 2021. PMID: 33016374
Obsessive compulsive disorder and the glutamatergic system.
Kariuki-Nyuthe C, Gomez-Mancilla B, Stein DJ. Kariuki-Nyuthe C, et al. Among authors: gomez mancilla b. Curr Opin Psychiatry. 2014 Jan;27(1):32-7. doi: 10.1097/YCO.0000000000000017. Curr Opin Psychiatry. 2014. PMID: 24270485 Review.
Tweaking the social network.
Gomez-Mancilla B. Gomez-Mancilla B. Sci Transl Med. 2012 Apr 25;4(131):131fs9. doi: 10.1126/scitranslmed.3004017. Sci Transl Med. 2012. PMID: 22539770
A white paper on a neurodevelopmental framework for drug discovery in autism and other neurodevelopmental disorders.
Díaz-Caneja CM, State MW, Hagerman RJ, Jacquemont S, Marín O, Bagni C, Umbricht D, Simonoff E, de Andrés-Trelles F, Kaale A, Pandina G, Gómez-Mancilla B, Wang PP, Cusak J, Siafis S, Leucht S, Parellada M, Loth E, Charman T, Buitelaar JK, Murphy D, Arango C. Díaz-Caneja CM, et al. Among authors: gomez mancilla b. Eur Neuropsychopharmacol. 2021 Jul;48:49-88. doi: 10.1016/j.euroneuro.2021.02.020. Epub 2021 Mar 27. Eur Neuropsychopharmacol. 2021. PMID: 33781629 Free article. Review.
The challenges of clinical trials in fragile X syndrome.
Jacquemont S, Berry-Kravis E, Hagerman R, von Raison F, Gasparini F, Apostol G, Ufer M, Des Portes V, Gomez-Mancilla B. Jacquemont S, et al. Among authors: gomez mancilla b. Psychopharmacology (Berl). 2014 Mar;231(6):1237-50. doi: 10.1007/s00213-013-3289-0. Epub 2013 Oct 31. Psychopharmacology (Berl). 2014. PMID: 24173622 Free PMC article. Review.
77 results